Welcome to the University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions. The funding of the CMCR is the result of SB 847 (Vasconcellos), passed by the State Legislature and signed into law by Governor Gray Davis. The legislation calls for a three year program overseeing objective, high quality medical research that will "enhance understanding of the efficacy and adverse effects of marijuana as a pharmacological agent," stressing that the project "should not be construed as encouraging or sanctioning the social or recreational use of marijuana" (SB 847).
The Center coordinates and supports cannabis research throughout the State of California. Research will focus on the potential medicinal benefits of cannabis for diseases and conditions as specified by the National Academy of Sciences, Institute of Medicine Report (1999) and by the Workshop on the Medical Utility of Marijuana, National Institutes of Health (1997). The following diseases and conditions constitute areas of emphasis for current CMCR funding:
- Severe appetite suppression, weight loss, and cachexia due to HIV infection and other medical conditions
- Chronic pain, particularly neuropathic pain
- Severe nausea and vomiting associated with cancer and its treatment
- Severe muscle spasticity caused by diseases such as multiple sclerosis
Investigators interested in conducting clinical trials involving medicinal cannabis should consult the Investigator Information section of this site.
Individuals interested in participating in CMCR studies should consult the Participant Information section of this site.